Par Drugs and Chemicals Ltd. Stock Analysis PAR.NS

Par Drugs & Chemicals Ltd. engages in the business of manufacturing active pharma ingredients and fine chemicals for domestic market as well as for exports to international markets. The company is headquartered in Vadodara, Gujarat and currently employs 121 full-time employees. The company went IPO on 2019-05-16. The firm manufactures a diverse range of antacid molecules. The Company’s products include magnesium hydroxide, magnesium trisilicate, magnesium carbonate, light magnesium oxide, magnesium oxide heavy, magnesium oxide USP, dried aluminum hydroxide gel, magaldrate, magnesium aluminum silicate hydrated, alma gate, hydrotalcite, aluminum hydroxide magnesium carbonate co-dried gel, aluminum-magnesium silicate BP, sodium aluminum silicate, precipitated silica, magnesium silicate, amorphous, colloidal silicon dioxide, and sucralfate USP. The firm owns and operates its manufacturing facilities at Bhavnagar in Gujarat. The company has over four manufacturing blocks at Bhavnagar, which are for different products, having a capacity of approximately 9,700 metric tons per annum.